Inventra 7 HF-T QP

Image
Inventra 7 HF-T QP
Inventra 7 HF-T QP
Image
Inventra 7 HF-T QP
Image
Inventra 7 HF-T QP
Image
Inventra 7 HF-T QP
Inventra 7 HF-T QP
Image
Inventra 7 HF-T QP
Image
Inventra 7 HF-T QP

Inventra 7 HF-T QP

Supercharged. When it counts.


5 Joules stronger; powerful Ultra-High Energy (UHE) therapy

  • The highest available energy at 42 Joules
  • Full protection, providing up to 8 shocks
  • Immediate protection right from the start

DFT and Your Patients

Inventra – Supercharged to Manage DFT

  • More physicians are considering no DFT testing at implant, based on SIMPLE study.1
  • Multiple studies have identified factors that may impact defibrillation efficacy. Cumulatively, these factors could increase defibrillation threshold significantly.
  • Up to 8% of patients have a high DFT 2


Risk Factors Decreasing Shock Efficacy

  • Non-ischemic cardiomyopathy2
  • Medication, e.g., amiodarone 3 or sildenafil4
  • Patients with right-sided implantations5
  • Large or tall patients with a greater body surface area6
  • Younger and active patients 3, 7, 8
  • Patients with larger left-ventricular size or mass and very poor left ventricular ejection fraction 7, 8


Extensive Options for Effective Defibrillation

  • Various options to maximize DFT safety margins
  • Multiple high-energy shocks - Up to 8 shocks per zone with 42 J max delivered energy
  • Multiple waveforms - Biphasic (Voltage controlled) - Biphasic 2 (Time controlled)
  • Multiple polarities - Normal - Reversed - Alternating – after first shock
  • Multiple shock pathways - RV → CAN + SVC - RV → CAN - RV → SVC


Product Features

  • CRT Optimization
  • ATP Optimization
  • DX System
  • Closed Loop Stimulation
  • BIOTRONIK Home Monitoring
  • Highly Competitive Longevity

Product Details

Image
Physician and nurse are looking at the patient status on the HMSC

BIOTRONIK Home Monitoring®

Image
Closed Loop Stimulation (CLS)

Closed Loop Stimulation


contact
Country/Region

1 Healey, Jeff S. et al. American Heart Journal, 2012. 164(2).

2 Lin, EF; Pacing and Clinical Electrophysiology, 2013. 36(2).

3 Napp A et al. European Heart Journal. 2010. 31.

4 Shinlapawittayatorn K et al. Journal of Cardiovascular Electrophysiology. 2006. 17(3).

5 Keyser A et al. Journal of Cardiothoracic Surgery. 2013. 8(77).

6 Lubiński A et al. Kardiologia Polska. 2005. 62(4).

7 Al-Ahmad A et al. Pacemakers and Implantable Cardioverter Defibrillators: An Expert’s Manual, Minneapolis, USA. Cardiotext Publishing; 2010.

8 Russo AM et al. Heart Rhythm Journal. 2005. 2(5).